Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
03 Jul 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/rd/faron-publishes-study-highlighting-role-of-sclever-1-as-immune-blocker-in-cancer-17348
02 Jul 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/biotechnology/faron-pharmaceuticals-ltd-director-dealing-1045234
12 Jun 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/biotechnology/faron-pharmaceuticals-presents-updated-phase-ii-data-from-bexmab-study-at-eha-2025-1038707
05 Jun 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-06-05/faron-pharmaceuticals-ltd-directorpca-dealing-and-donation-of-shares-to-foundation
05 Jun 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/biotechnology/faron-pharmaceuticals-ltd-director%2fpca-dealing-and-donation-of-shares-to-foundation-1036017
02 Jun 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/biotechnology/faron-pharmaceuticals-presents-phase-ii-data-from-bexmab-study-at-asco-2025-1034350
ABOUT THIS PAGE